(Q54240863)

26 May 2018

title

Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. (English)

1 reference

26 May 2018

author name string

Kinsella JP

1

1 reference

26 May 2018

Toews WH

2

1 reference

26 May 2018

Henry D

3

1 reference

26 May 2018

Abman SH

4

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 May 1993

1 reference

26 May 2018

The Journal of Pediatrics

published in

1 reference

26 May 2018

volume

122

1 reference

26 May 2018

issue

5 Pt 1

1 reference

26 May 2018

page(s)

803-806

1 reference

26 May 2018

Primary pulmonary hypertension. A national prospective study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

Inhaled Nitric Oxide A Selective Pulmonary Vasodilator of Heparin-Protamine Vasoconstriction in Sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980032-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(06)80032-6

1 reference

26 May 2018

1 reference

26 May 2018